 | iTeos Therapeutics, Inc. | |||
| NGM : ITOS || Location: United States | ||||
$10.17-0.16 (-1.55%) |
0.09 M | 10.01 - 10.53 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.047 M |
| March 15, 2024 | 2.015 M |
| Feb. 29, 2024 | 1.800 M |
| Feb. 15, 2024 | 1.704 M |
| Jan. 31, 2024 | 1.731 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.05 | -0.85 | 19.35% |
| 09/30/2023 | -1.23 | -0.90 | 26.68% |
| 06/30/2023 | -1.05 | -0.96 | 8.62% |
| 03/31/2023 | -1.01 | -0.44 | 56.62% |
| 09/30/2022 | 0.10 | 0.03 | -69.85% |
ITOS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 35.843M | Shares Float | 24.786M |
| Short Float | 2.047M | Market Cap | 370.26M |
| Institution ownership | 0.00% | Insider ownership | 0.542% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.15 | Forward EPS | -6.19 |